chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I contracted COVID-19 on 05/23/2022 with symptoms of fatigue, runny nose, cough, congestion, and myalgia. I thought it was allergies initially until I did a COVID-19 rapid nasal swab home test was positive on 05/28/2022. I went to a conference 05/20 to 05/22 and received an exposure notification via email, and when I tested initially it was negative. I was ill for 7 to 8 days until my symptoms began to resolve, but I still have a slight lingering cough.
On May 26, I tested positive for COVID. My great niece and nephew, who I care for tested positive on 5/21/22.  My niece  who was fully vaccinated and boosted with one shot tested positive on 5/24/22. My other great niece tested positive on the 24th also. My sister also tested positive on 5/26. The twin girls who are 3 were to young to be vaccinated. Their daycare center stopped requiring masks in March and stopped notifying parents in May when someone tested positive at the center. My 6 year old nephew was also vaccinated   We always wore masks in public.
Right Arm rash, hard, warm-to-touch, 2-3cm below injection site, area enlarged each day (two days)
Headaches; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headaches". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rapid/racing heartbeat, light/swimmy headed, extreme fatigue including excessive yawning,  Headache, Body aches, fever.
On Friday, 08/02/2002 child had fever of 102 degrees axillary temp. Continued with off and on low grade fever through weekend. Sunday 08/04/2002 began itching back. Monday 08/05/2002 broke out in hive- like rash throughout trunk. Continuous having low grade fever.
Vaccine administered after being out of temp range. Per Dr. who spoke to guardian no adverse reactions have been noticed at this time.
Redness/pain/warmth at injection site measuring approximately 5.5cm x 5cm.  Patient 28 weeks pregnant.
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 29-MAR-2016, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) (which had a lot # L031065 and an expiration date of 18-AUG-2017; however dose, dosage number, anatomical location and route of administration were not reported). The temperature excursion involved was 0 degree C for a time frame of 7 hours. However, no adverse effects were reported. Additionally, it was stated that a previous temperature excursion of 4.5 degree C had occurred for a time frame of 14 hours. Also, no product quality complaint was involved. Additional information is not expected since consent to be contracted for follow up was denied.
Injection site pain; Body aches; This is a spontaneous report from a contactable nurse (reporting for self).  A 37-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE),  lot number EL1283, intramuscularly on 09Jan2021 as a single dose (Dose 2), for COVID-19 immunization.  Medical history included depression. The patient had not experienced COVD prior to vaccination. The patient had no known allergies.  Concomitant medication included bupropion hydrochloride (WELLBUTRIN).  The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number EK5730 as a single dose (Dose 1) on 09Jan202110:00 right arm, for COVID-19 immunization. There was no other vaccine administered in the 4 weeks prior to the COVI-19 vaccination. There was no reaction with the 1st dose. With the 2nd dose, the patient experienced injection site pain and body aches for 24 hours, onset Jan2021. There was no treatment received for the event. The outcome of the events injection site pain and body aches was recovered in Jan2021.
This spontaneous report received from a medical assistant refers to an approximately 2-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided. On 03-AUG-2012 the patient was vaccinated with the first dose of M-M-R II injection (rHA; subcutaneously; lot # H014648, expiration date: 20-NOV-2013; dose was not provided), and the first dose of VARIVAX injection (subcutaneously; lot# H018788, expiration date: 15-OCT-2014; dose was not provided). Then, on 21-AUG-2013 (reported as "approximately one year later"), the patient received the second dose of M-M-R II injection (rHA; subcutaneously; lot # 0232AE, expiration date: 26-JAN-2014; dose was not provided), and the second dose of VARIVAX injection (subcutaneously; lot# 0048AE, expiration date: 20-DEC-2013; dose was not provided). No adverse events were noted by reporter. Product Quality Complaint (PQC) was not involved. Additional information has been requested.
Information has been received from a nurse concerning a 26 year old female patient who on 10-JUL-2007 was vaccinated with the first dose of Gardasil (Lot # 658490/0802U). On 10-JUL-2007, within ten minutes of the vaccination, the patient fainted. Unspecified medical attention was sought. On 10-JUL-2007, the patient recovered. This report is one of two reports from the same source. Additional information has been requested.
Information has been received on 31-OCT-2017 regarding a case in litigation from a lawyer and a male consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medication were not reported. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported), subcutaneous on or about 12-APR-2011 by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent zoster keratitis and other eye disorders. On or about 23-NOV02011, the patient was treated by a physician at an eye health center for eye problems which were diagnosed as zoster keratitis, a painful ocular disorder involving vision interference due to the herpes zoster virus infecting the eye. On or about 25-NOV02011, the patient sought subsequent treatment from another physician at an eye health center for ongoing and worsening symptoms of keratitis. On or about 23-OCT-2014, the patient sought subsequent medical treatment from an eye care physician's office for ongoing and worsening symptoms, at which time the diagnosis of progressive disciform keratitis was affirmed. On or about 22-JUN-2015, the patient was treated again by an eye care physician for new and worsening symptoms, where new herpes infections were observed in the left eye. Between the dates of 10-NOV-2015 and 08-FEB-2017, the patient underwent continuous observation and treatment by a physician for complications of the viral condition in his eyes. The patient has been prescribed MEDROL, acyclovir, VIGAMOX, doxycycline-monohydrate, tea tree oil, REFRESH PLUS drops, and prednisone for management his persistent and painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, persistent zoster keratitis, progressive disciform keratitis and new herpes infections were observed in the left eye were considered to be medically significant. Additional information has been requested.
Patient with 2 COVID vaccines who admitted with COVID detected PCR and PNA.  Provider d/c note:  "77 yoF with a history of Afib, T2DM, PE, HTN, seizures, and chronic pruritus who presented to ER for generalized weakness and GLF found to have COVID PNA, not needing decadron or Remdesivir due to clinical stability. Her stay was complicated by MRSA bacteremia without overt source, but likely from chronic non healing extremity wounds, so Vancomycin initiated with continuations through 10/3/22. There was concern for mycosis fungoides given her chronic overwhelming pruritus in setting of non healing wounds, so biopsy was done demonstrating spongiotic dermatis. Steroid cream and topical benadryl added with escalation of anti pruritic agents and referral to dermatology ordered prior to discharge. She was discharged in a stable condition to SNF with appropriate follow up."
pressure in throat, cough, difficulty breathing, dizzy. Refused transport. Evaluated by EMS-Cleared
Office Visit   10/28/2021  Dyspnea, unspecified type +3 more Dx Follow-up  Reason for Visit Dyspnea, unspecified type  -     X-ray chest 2 views; Future  Hospital discharge follow-up  Chronic respiratory failure with hypoxia, on home oxygen therapy Benign essential hypertension    Patient Instructions Patient's hospitalization reviewed.  I did see her October 21, on October 23 she was admitted to Hospital with shortness of breath.  Original x-ray did show a small patchy opacity consider infiltrate versus atelectasis.  On further evaluation, patient's white blood cell count was normal, pro calcitonin was normal.  Overall, not felt to be pneumonia, a COPD exacerbation, or a congestive heart failure exacerbation.  She was sent home on prednisone.   Patient tells me that she still is feeling a bit short of breath. Her oxygen saturation here in the office today is 99%. She is not tachycardia, low likelihood of pulmonary embolism as the patient is on Eliquis and saturating normally.   On examination, she does have very slight decreased breath sounds at the left lower lung base.  Patient is due for fasting blood work, I have ordered a chest x-ray as well for the patient have done.  I would just like to ensure there is no new or potential worsening infiltrate that would be indicative of pneumonia.  I did advise the patient to order to start checking her oxygen saturations on a daily basis with her vitals.  Certainly, if she has persistently low 90s on oxygen saturation with her baseline oxygen, she is to let us know right away.   ED to Hosp-Admission Discharged   10/30/2021 - 11/2/2021 (3 days) Admission Shortness of breath     Hospital Course This is a 82-year-old lady with history of diastolic congestive heart failure, COPD on home oxygen 2 L, CKD stage III, coronary artery disease, atrial fibrillation on anticoagulation with Eliquis and diabetes mellitus who was brought in Hospital emergency department due to cough and shortness of breath.  She was admitted for work-up and she was found to be positive for COVID-19 infection.  Chest x-ray did not show any evidence of pneumonia.  She was treated for COVID-19 infection with dexamethasone.  She remained stable on 2 L oxygen.  She on admission she was also bit confused so she had acute metabolic encephalopathy likely due to hypoglycemia.  Her mental status did improve as her blood sugar got better.   On day of discharge her breathing is better.  She is still having some occasional cough with clear color sputum.  Remains afebrile.  No other new symptoms or acute event as per nursing staff
ADMINISTERED THE VACCINE TWO DAYS PAST EXPIRATION DATE; This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 23-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-SEP-2021, the patient experienced administered the vaccine two days past expiration date. The action taken with covid-19 vaccine was not applicable. The outcome of administered the vaccine two days past expiration date was not reported. This report was non-serious.
Near syncope.  Place head between legs then placed patient on floor with feet up.  Vital signs stable with BP dropping to 80/50 but rising to 100/80 with recumbency.   EMS activated and responded.  Patient taken by EMS and treated and released.  Adverse reaction report was incorrect. Patient had a local hive like reaction at the injection site, treated at the clinic with ice.Discharged home.
unwell; low platelets; fatigue; low grade fever; decreased appetite; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation; Lenvatinib mesilate (LENVIMA), via an unspecified route of administration from 01Feb2021 (Batch/Lot number was not reported) to an unspecified date, at 24 mg for an unspecified indication. Medical history included thyroid cancer from an unknown date and unknown if ongoing, decreased appetite from an unknown date and unknown if ongoing, chemotherapy from an unknown date and unknown if ongoing, smoking cessation therapy from an unknown date to Sep2020 (quit 9/2020). The patient's concomitant medications were not reported. The patient experienced unwell on an unspecified date with outcome of unknown, low platelets on an unspecified date, fatigue on an unspecified date, low grade fever on an unspecified date, decreased appetite on an unspecified date. The patient underwent lab tests and procedures which included platelet count: low on. The action taken in response from Lenvatinib mesilate was unknown. The outcome of the events malaise, platelet count decreased, fatigue, pyrexia, decreased appetite was unknown.  No follow-up attempts are needed. No further information is expected.
got 2nd dose after 6 months past the 1st; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose 0.5 ml received in November 2019 on an unknown arm).   On 27th July 2022, the patient received Shingrix .5 ml. On 27th July 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.     Additional Information: Additional Information: GSK Receipt Date: 02-AUG-2022. Reporter's Comments: The case was reported by patient's wife. The patient was vaccinated with Shingrix at an unknown arm. The patient got his 2nd Shingrix vaccine greater than 6 months past the first vaccine. The reporter did not want to give any further demographics or details and did not had any information about the vaccine itself. The reporter did not consent to follow up. No HCP for follow up. Additional Supportive Information: The patient received 2nd dose shingrix late than recommended interval, which led to lengthening of vaccination schedule.
Pt received vaccines about 10 am, then later that afternoon he was fussy, then about 5:30pm he started screaming and refusing to move his thighs. Mom noted a rash all over his thighs, white spots one finger width in diameter surrounded by red. Mom says they were raised looked like an insect bite to her.  She called for EMS. The lesions were resolving by the time they arrived. They were gone after about 30 minutes. Afterwards pt was fine just complaining of soreness to his thighs. The next day, pt was acting himself. No fever.
Developed left sided neuropathy/burning followed the next day by right sided neuropathy/burning. Right foot maintained this neuropathy sensation for several days followed by numbness that will turn to burning sensation with continuous pressure. Treated with Aleve with temporary relief of burning but continued numb sensation. This sensation has now increased with worsening burning sensations.
vomiting, respiratory distress, wheezing satrted at aprroximately 5:45  t which time patient was instructed to go to the nearest Emergency room. Patient was evaluated and treated in the ER ith IM epinephrine, PO decadron and admitted for evaluation. Patient did well during the course of his stay and improved from the treament and released on 8/24/2022
arm was sore; patient received booster dose of Pfizer; patient received booster dose of Pfizer; flushing; warmth sensation; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number: FC3180, Expiry date: Unknown) via an unspecified route of administration on 08Aug2021 as dose 3, single for COVID-19 immunisation. The patient previously received first dose of BNT162B2 for COVID-19 immunization dose 1 (Pfizer Lot: EL0142) on 12Jan2021 and experienced arm pain the next day, fatigue, malaise x 7 days, periodic migraine headaches. The patient received second dose of BNT162B2 for COVID-19 immunization as dose 2 (Pfizer lot: EL3247) on 02Feb2021 and experienced sore arm the next day. Medical history included hiv infection, meniere's disease, autoimmune disorder, polypharmacy, Ménière's disease symptoms have worsened with increased hearing loss verified by ENT all from unspecified date and unknown if ongoing. The patient's concomitant medications were not reported. On 08Aug2021, the patient experienced flushing, warmth sensation, patient received booster dose of Pfizer. On 09Aug2021, the patient experienced arm was sore. The outcome for flushing and warmth sensation was recovered on 08Aug2021, patient received booster dose of Pfizer and arm was sore was unknown.  No follow-up attempts are possible. No further information is expected.
Headache, chills, fever of 101.2, weakness, nausea lasted 37 hours.
I had dyspnea and palpitations started about 5 minutes after vaccination, lasted about 2 minutes. I had similar another episode after about 9-10 minutes after vaccination which is less severe compare to first one.  I was sent to ER after second episode for close monitoring.  No event on tele monitor in ER.
Kidney failure,  fever, headaches, fever blisters, clotting, cellulitis. Admitted to the emergency room for 5 days
Itchiness at injection site immediately after injection on 2/9/2021. Large -2-3 inch- raised, red, hard, area at injection site 2/22/2021
The inoculation site is a bit tender and as soon as I got the vaccine it was fine and then the pain started after a couple of minutes. No other symptoms in the following two hours after the shot.
Patient received 2nd dose 8/24/21 and says she's been having arm and hand muscle pain since 9/1/21.
heart rate jumped up pretty high; injection site was raised it is red, its hot, there are bumps on it, and it itches; injection site was raised it is red, its hot, there are bumps on it, and it itches; injection site was raised it is red, its hot, there are bumps on it, and it itches; injection site was raised it is red, its hot, there are bumps on it, and it itches; arm hurts and she can barely raise or move it at all; arm hurts and she can barely raise or move it at all; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 15Nov2021 (Lot number: SH8030) at the age of 32 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose, Lot: ER8727), administration date: 24Apr2021, when the patient was 31 years old, for COVID-19 Immunization, reaction(s): "felt sick for a couple of days"; Bnt162b2 (Second dose, Lot: EW0168), administration date: 15May2021, when the patient was 31 years old, for COVID-19 Immunization, reaction(s): "felt sick for a couple of days". The following information was reported: HEART RATE INCREASED (non-serious) with onset 16Nov2021, outcome "recovered" (18Nov2021), described as "heart rate jumped up pretty high"; VACCINATION SITE ECZEMA (non-serious), VACCINATION SITE WARMTH (non-serious), VACCINATION SITE RASH (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 16Nov2021, outcome "not recovered" and all described as "injection site was raised it is red, its hot, there are bumps on it, and it itches"; PAIN IN EXTREMITY (non-serious), MOBILITY DECREASED (non-serious) all with onset 16Nov2021, outcome "not recovered" and all described as "arm hurts and she can barely raise or move it at all". The events "heart rate jumped up pretty high", "injection site was raised it is red, its hot, there are bumps on it, and it itches", "injection site was raised it is red, its hot, there are bumps on it, and it itches", "injection site was raised it is red, its hot, there are bumps on it, and it itches", "injection site was raised it is red, its hot, there are bumps on it, and it itches", "arm hurts and she can barely raise or move it at all" and "arm hurts and she can barely raise or move it at all" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Additional information: time the vaccination was given: between 18: 00-19: 00. She called her primary care and has an appointment for tomorrow.
Headache, SkinRash, Arm swelling, left arm rash, leg rash fatigue, diaphoresis Narrative: Pt experienced the following ADR after 1st dose of covid vaccine: Arm swelling, left arm rash, leg rash fatigue, headache, diaphoresis. Pt did not treat with any medication. Symptoms resolved on its own.
Day after pain in the area of my lung scar and under arm , skin rashes as well in chest, they come back and then it was fine for a while but recently in June with Heatwave 1 and currently heatwave2- I  felt horrible pressure and pain in my chest and could not breath and the nebulizer wasnt helping. I got an xray and the doctor at the City Md refused to believe me that this was related to vaccine and my lung wound from a previous surgery that increases inflammation as I am now experiencing.  I am asking to please help me get a cooling airc conditioner in my kitchen/ bathroom area as it is also where I will be teaching virtually hybrid schedule and only feel relieved in cool air. My school that I teach at is in some rooms adding daily heat exhaustion and  I would greatly like if possible any help or treatment and or rehabiliation phyical therapy and also reexamining the area where my origial surgery was and how this can be dangerous  for people taking the vaccine.